Evidence map›Paper›PMID 42698547›Full record

ArticleFrontiers in pharmacology2026

Hyaluronidase treatment is associated with increased cytokine levels and reduced peritoneal neutrophil accumulation during LPS-induced inflammation.

Karla de Castro Figueiredo Bordon, Karina Furlani Zoccal, Sayuri Noemi Otuka, Mouzarllem Barros Reis, Cryslane Almeida de Lima, Ualter Guilherme Cipriano, Vania Luiza Deperon Bonato, Eliane Candiani Arantes

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karla de Castro Figueiredo BordonDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.
Karina Furlani ZoccalDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.
Sayuri Noemi OtukaDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.
Mouzarllem Barros ReisDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.
Cryslane Almeida de LimaBarão de Mauá University Center (CUBM), Ribeirão Preto, Brazil.
Ualter Guilherme CiprianoBasic and Applied Immunology Program, Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.
Vania Luiza Deperon BonatoBasic and Applied Immunology Program, Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.
Eliane Candiani ArantesDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hyaluronidases are classically described as spreading factors that facilitate venom dissemination through extracellular matrix degradation, but their immunomodulatory roles remain poorly defined. In particular, comparative data between native scorpion venom hyaluronidase and commercial bovine hyaluronidase remain limited. This study investigated whether hyaluronidase treatment was associated with condition-dependent changes in inflammatory parameters. Methods: BALB/c mice were subjected to lipopolysaccharide (LPS)-induced peritoneal inflammation and treated with a native Results: Under non-LPS conditions, both TsHyal-1 and PH20 increased neutrophil recruitment and IL-6/IL-1β levels, accompanied by mild to moderate tissue alterations. In contrast, during LPS-induced peritoneal inflammation, both enzymes induced a non-canonical inflammatory profile in which IL-6/IL-1β levels were increased while neutrophil recruitment was reduced. TsHyal-1 exhibited a more pronounced immunomodulatory profile than bovine PH20. These differences were observed despite equivalent catalytic activity and nearly molar dosing and may reflect intrinsic biochemical or structural characteristics of the enzymes. Conclusion: Treatment with TsHyal-1 and bovine PH20 was associated with context-dependent changes in inflammatory parameters in this experimental model. These findings expand current knowledge of hyaluronidase biology and provide a basis for future studies investigating their role in inflammatory regulation under defined inflammatory contexts.

Indexed as

drug discoveryextracellular matrixglycocalyxhyaluronic acidinnate immunityleukocyte traffickingtranslational pharmacologyvenom-derived therapeutics

Identifiers

PMID42698547
PMCPMC13541562

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.